These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27870451)

  • 1. Preclinical sex differences in depression and antidepressant response: Implications for clinical research.
    Kokras N; Dalla C
    J Neurosci Res; 2017 Jan; 95(1-2):731-736. PubMed ID: 27870451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Depression and Anxiety.
    Pavlidi P; Kokras N; Dalla C
    Curr Top Behav Neurosci; 2023; 62():103-132. PubMed ID: 35915385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in animal models of depression and antidepressant response.
    Dalla C; Pitychoutis PM; Kokras N; Papadopoulou-Daifoti Z
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):226-33. PubMed ID: 20050844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research.
    López-Rubalcava C; Estrada-Camarena E
    J Ethnopharmacol; 2016 Jun; 186():377-391. PubMed ID: 27021688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study.
    Yang SJ; Kim SY; Stewart R; Kim JM; Shin IS; Jung SW; Lee MS; Jeong SH; Jun TY
    Psychiatry Res; 2011 Aug; 189(1):82-90. PubMed ID: 21216471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior.
    Kreiner G; Chmielarz P; Roman A; Nalepa I
    Pharmacol Rep; 2013; 65(6):1580-90. PubMed ID: 24553006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in depression and antidepressant pharmacokinetics and adverse events.
    Frackiewicz EJ; Sramek JJ; Cutler NR
    Ann Pharmacother; 2000 Jan; 34(1):80-8. PubMed ID: 10669189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of gender on antidepressants.
    Sramek JJ; Cutler NR
    Curr Top Behav Neurosci; 2011; 8():231-49. PubMed ID: 21374019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of magnesium and zinc in depression: similarities and differences.
    Szewczyk B; Szopa A; Serefko A; Poleszak E; Nowak G
    Magnes Res; 2018 Aug; 31(3):78-89. PubMed ID: 30714573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression Assessment in Clinical Trials and Pre-clinical Tests: A Critical Review.
    Ferreira MF; Castanheira L; Sebastião AM; Telles-Correia D
    Curr Top Med Chem; 2018; 18(19):1677-1703. PubMed ID: 30430942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study.
    Soudry A; Dufouil C; Ritchie K; Dartigues JF; Tzourio C; Alpérovitch A
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):324-30. PubMed ID: 17907265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance.
    Walker AJ; Foley BM; Sutor SL; McGillivray JA; Frye MA; Tye SJ
    Behav Brain Res; 2015 Oct; 293():198-202. PubMed ID: 26209292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
    Kulkarni SK; Akula KK; Deshpande J
    Pharmacology; 2012; 89(1-2):83-90. PubMed ID: 22343362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Creation of a line of "depressed" mice from a selection of breeders exhibiting a behavioral helplessness].
    Vaugeois JM; Costentin J
    C R Seances Soc Biol Fil; 1998; 192(6):1149-61. PubMed ID: 10101610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.
    Bies RR; Bigos KL; Pollock BG
    J Gend Specif Med; 2003; 6(3):12-20. PubMed ID: 14513571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.